The numbers are stark, and they should make us nervous. More than 40% of traded mammal species share at least one pathogen with humans, compared with only 6% of non-traded mammals. That's not a marginal difference. That's a systematic amplification of pandemic risk built directly into the global wildlife trade.
The research, published in Nature, analyzed pathogen data across thousands of mammal species and found something troubling: the very act of trading wildlife appears to concentrate disease risk. It's not just that we're moving animals around—we're preferentially selecting and moving the ones most likely to carry zoonotic pathogens.
Think of it as a kind of epidemiological filter. Wild mammals that end up in trade tend to be generalists—species that can thrive in human-modified environments, tolerate stress, and host diverse parasite communities. Those same traits make them excellent disease vectors.
The COVID-19 pandemic offered a brutal lesson in how quickly a pathogen can jump from wildlife into human populations and spiral into a global crisis. Yet the wildlife trade that may have facilitated that spillover has largely continued. This study quantifies just how much risk that trade carries.
Now, this doesn't mean every traded animal is a walking biohazard. The research shows capacity for pathogen sharing, not active transmission. Most of these pathogens never make the jump to humans. But the ones that do—SARS, MERS, HIV, Ebola—tend to be catastrophic.
The research also reveals geographic patterns. Southeast Asia, Central Africa, and parts of Latin America emerge as hotspots where high wildlife trade volumes overlap with rich mammal diversity. These are the regions where surveillance and regulation matter most.
There's a policy dimension here that's worth noting. Post-COVID, many governments pledged to strengthen wildlife trade regulations. Some did. Others quietly resumed business as usual. This research gives those policy conversations concrete epidemiological grounding: traded wildlife carry disease risk at seven times the rate of non-traded species.
The science is elegant in its simplicity. The researchers compiled existing pathogen databases, cross-referenced them with trade data, and let the statistics speak. No lab work, no field expeditions—just careful analysis of what we already know, revealing patterns we'd failed to see.
